BNGO
Bionano Genomics, Inc.Company with tickers: BNGO
CIK
1411690
CUSIP
09075F404
Shares Outstanding
11,475,000
Website
https://www.bionano.com
13F Activity (30d)
2 filings
1 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Alka Chaubey, Ph.D. | Chief Medical Officer | Resigned | 2026-06-05 |